Riina Richardson
Riina Richardson
Verified email at - Homepage
Cited by
Cited by
The global problem of antifungal resistance: prevalence, mechanisms, and management
DS Perlin, R Rautemaa-Richardson, A Alastruey-Izquierdo
The Lancet infectious diseases 17 (12), e383-e392, 2017
Global burden of recurrent vulvovaginal candidiasis: a systematic review
DW Denning, M Kneale, JD Sobel, R Rautemaa-Richardson
The Lancet infectious diseases 18 (11), e339-e347, 2018
Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I
ES Husebye, J Perheentupa, R Rautemaa, O Kämpe
Journal of internal medicine 265 (5), 514-529, 2009
Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris
L Sherry, G Ramage, R Kean, A Borman, EM Johnson, MD Richardson, ...
Emerging infectious diseases 23 (2), 328, 2017
Bacterial aerosols in dental practice–a potential hospital infection problem?
R Rautemaa, A Nordberg, K Wuolijoki-Saaristo, JH Meurman
Journal of hospital infection 64 (1), 76-81, 2006
The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus
MG Fraczek, M Bromley, A Buied, CB Moore, R Rajendran, R Rautemaa, ...
Journal of Antimicrobial Chemotherapy 68 (7), 1486-1496, 2013
Oral infections and systemic disease—an emerging problem in medicine
R Rautemaa, A Lauhio, MP Cullinan, GJ Seymour
Clinical Microbiology and Infection 13 (11), 1041-1047, 2007
Oral candidosis–clinical challenges of a biofilm disease
R Rautemaa, G Ramage
Critical reviews in microbiology 37 (4), 328-336, 2011
Acetaldehyde production from ethanol by oral streptococci
J Kurkivuori, V Salaspuro, P Kaihovaara, K Kari, R Rautemaa, L Grönroos, ...
Oral oncology 43 (2), 181-186, 2007
Immunohistochemical localization of Toll‐like receptors 1–10 in periodontitis
A Beklen, M Hukkanen, R Richardson, YT Konttinen
Oral microbiology and immunology 23 (5), 425-431, 2008
Pulmonary cryptococcosis: a review of pathobiology and clinical aspects
F Setianingrum, R Rautemaa-Richardson, DW Denning
Medical mycology 57 (2), 133-150, 2019
Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo
A Järvensivu, J Hietanen, R Rautemaa, T Sorsa, M Richardson
Oral diseases 10 (2), 106-112, 2004
Oral and oesophageal squamous cell carcinoma–a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I)
R Rautemaa, J Hietanen, S Niissalo, S Pirinen, J Perheentupa
Oral oncology 43 (6), 607-613, 2007
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of …
J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ...
Clinical Microbiology and Infection 28 (4), 580-587, 2022
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
M Bassetti, DR Giacobbe, A Vena, C Trucchi, F Ansaldi, M Antonelli, ...
Critical Care 23, 1-7, 2019
Complement-resistance mechanisms of bacteria
R Rautemaa, S Meri
Microbes and Infection 1 (10), 785-794, 1999
Predictors of mortality in chronic pulmonary aspergillosis
D Lowes, K Al-Shair, PJ Newton, J Morris, C Harris, ...
European Respiratory Journal 49 (2), 2017
Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance
R Kean, C Delaney, L Sherry, A Borman, EM Johnson, MD Richardson, ...
Msphere 3 (4), 10.1128/msphere. 00334-18, 2018
Analysis of systemic and local odontogenic infection complications requiring hospital care
L Seppänen, A Lauhio, C Lindqvist, R Suuronen, R Rautemaa
Journal of Infection 57 (2), 116-122, 2008
Effect of pH on In Vitro Susceptibility of Candida glabrata and Candida albicans to 11 Antifungal Agents and Implications for Clinical Use
CS Danby, D Boikov, R Rautemaa-Richardson, JD Sobel
Antimicrobial agents and chemotherapy 56 (3), 1403-1406, 2012
The system can't perform the operation now. Try again later.
Articles 1–20